Latest Market News

Gorilla Gold’s first diamond drilling at Mulwarrie reveals impressive high-grade gold intercepts, setting the stage for a significant resource upgrade in Q3 2025. The ongoing program is expanding mineralisation beyond the current 78,700-ounce resource.

McLaren Minerals has successfully raised $1.282 million through a two-tranche placement to advance its McLaren Titanium Project in Western Australia, aiming to complete a critical pre-feasibility study by early Q3 2025.

AusQuest Limited has initiated a significant Stage 2 drilling campaign at its Cangallo copper-gold project in Peru, aiming to expand promising mineralisation and pinpoint the porphyry system’s core. Initial assay results are anticipated within two months.

Opyl Limited has secured strategic collaborations with two leading contract research organisations, integrating its AI-driven TrialKey platform into cardiovascular, oncology, and rare disease clinical trials to enhance trial design and accelerate commercial growth.

Alvo Minerals Limited has had its trading suspension lifted immediately following the release of details about its Entitlement Offer, signaling renewed market activity.

Close the Loop Limited reports steady revenue but a sharp 50% drop in EBITDA for the second half of FY25, driven by operational challenges in North America. A leadership change and strategic shifts aim to stabilise growth.

Cettire Limited reports a slight 1.7% increase in sales revenue for the year-to-date FY25 amid ongoing global luxury market challenges, including US tariff impacts and volatile demand. The company focuses on emerging markets expansion and improving profitability despite margin pressures.

ASX Limited’s 2025 Investor Forum reveals steady progress on its five-year strategy, highlighting technology modernization, operational risk management, and a focus on data-driven growth. The exchange outlines capital expenditure plans and expense controls aimed at sustaining shareholder value amid evolving market demands.

Aguia Resources is ramping up production at its high-grade Santa Barbara gold project in Colombia while advancing a low-capital phosphate operation in Brazil, setting the stage for robust cash flow generation.

ASX Limited reveals steady progress on its FY28 strategy, emphasizing technology modernization and operational resilience while providing detailed financial guidance through FY27.

Cleo Diagnostics unveils a pioneering blood test for early ovarian cancer detection, boasting superior accuracy to existing methods and targeting a significant U.S. market opportunity.

Bioxyne Limited has raised its FY2025 revenue guidance to $28 million, driven by explosive growth in Australian pharmaceutical manufacturing and the upcoming commercial production of MDMA capsules. The company is also making strides in expanding its footprint across Europe.